• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

异位妊娠手术及临床治疗后的输卵管通畅情况。

Tubal patency following surgical and clinical treatment of ectopic pregnancy.

作者信息

Elito Junior Julio, Han Kyung Koo, Camano Luiz

机构信息

Department of Obstetrics, Escola Paulista de Medicina, Universidade Federal de São Paulo, Rua Maria Carolina 68, Jardim Paulistano, São Paulo (SP), CEP 01445-000, Brazil.

出版信息

Sao Paulo Med J. 2006 Sep 7;124(5):264-6. doi: 10.1590/s1516-31802006000500005.

DOI:10.1590/s1516-31802006000500005
PMID:17262156
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11068293/
Abstract

CONTEXT AND OBJECTIVE

As there is little information about fertility outcomes among women following clinical treatment (methotrexate and expectant management) and surgery (salpingectomy) consequent to ectopic pregnancy, we evaluate the results from hysterosalpingography subsequent to treatment. The objective was to evaluate contralateral tubal patency using hysterosalpingography following surgery and clinical treatment of tubal pregnancy.

DESIGN AND SETTING

This was a prospective study at the Department of Obstetrics of Universidade Federal de São Paulo, a tertiary center.

METHOD

Among 115 patients who underwent hysterosalpingography following surgery and clinical treatment of tubal pregnancy between April 1994 and February 2002, 30 were treated with a single intramuscular dose of methotrexate (50 mg/m(2)), 50 were followed up expectantly and 35 underwent salpingectomy.

RESULTS

The patency of the ipsilateral tube was 84% after methotrexate treatment and 78% after expectant management. In addition, contralateral tubal patency was 97% after methotrexate treatment, 92% after expectant management and 83% after salpingectomy. There were no statistically significant differences between the clinical treatment and surgery groups.

CONCLUSIONS

The findings from this study suggest similar contralateral tubal patency rates following salpingectomy, methotrexate treatment and expectant management.

摘要

背景与目的

由于关于异位妊娠临床治疗(甲氨蝶呤及期待治疗)和手术(输卵管切除术)后女性生育结局的信息较少,我们评估了治疗后子宫输卵管造影的结果。目的是通过子宫输卵管造影评估输卵管妊娠手术和临床治疗后对侧输卵管的通畅情况。

设计与地点

这是一项在圣保罗联邦大学妇产科进行的前瞻性研究,该科室为三级医疗中心。

方法

在1994年4月至2002年2月期间接受输卵管妊娠手术和临床治疗后进行子宫输卵管造影的115例患者中,30例接受单次肌内注射甲氨蝶呤(50 mg/m²)治疗,50例进行期待随访,35例行输卵管切除术。

结果

甲氨蝶呤治疗后同侧输卵管通畅率为84%,期待治疗后为78%。此外,甲氨蝶呤治疗后对侧输卵管通畅率为97%,期待治疗后为92%,输卵管切除术后为83%。临床治疗组和手术组之间无统计学显著差异。

结论

本研究结果表明,输卵管切除术、甲氨蝶呤治疗和期待治疗后对侧输卵管通畅率相似。

相似文献

1
Tubal patency following surgical and clinical treatment of ectopic pregnancy.异位妊娠手术及临床治疗后的输卵管通畅情况。
Sao Paulo Med J. 2006 Sep 7;124(5):264-6. doi: 10.1590/s1516-31802006000500005.
2
Tubal patency after clinical treatment of unruptured ectopic pregnancy.未破裂型异位妊娠临床治疗后的输卵管通畅情况。
Int J Gynaecol Obstet. 2005 Mar;88(3):309-13. doi: 10.1016/j.ijgo.2004.12.018. Epub 2005 Jan 22.
3
Reproductive potential after methotrexate treatment of ectopic gestation in a community hospital.社区医院中异位妊娠经甲氨蝶呤治疗后的生殖潜能
J Reprod Med. 1999 Apr;44(4):335-8.
4
Frequency and related factors of tubal patency after methotrexate treatment in women with ectopic pregnancy.宫外孕女性甲氨蝶呤治疗后输卵管通畅的频率及相关因素
J Obstet Gynaecol Res. 2016 Mar;42(3):286-90. doi: 10.1111/jog.12894. Epub 2015 Dec 22.
5
Disparities in the management of ectopic pregnancy.异位妊娠管理中的差异。
Am J Obstet Gynecol. 2017 Jul;217(1):49.e1-49.e10. doi: 10.1016/j.ajog.2017.03.001. Epub 2017 Mar 10.
6
Tubal patency after local methotrexate injection for tubal pregnancy.输卵管妊娠局部注射甲氨蝶呤后的输卵管通畅情况。
Lancet. 1989 Oct 21;2(8669):967-8. doi: 10.1016/s0140-6736(89)90966-5.
7
Assessment of β-human chorionic gonadotropin level as a reliable predictor of tubal patency confirmed with transvaginal ultrasound-guided selective salpingography (TVSSG) following conservative treatment of tubal pregnancy.评估β-人绒毛膜促性腺激素水平作为保守治疗输卵管妊娠后经阴道超声引导选择性输卵管造影术(TVSSG)证实输卵管通畅的可靠预测指标。
Arch Gynecol Obstet. 2012 Apr;285(4):1043-8. doi: 10.1007/s00404-011-2104-6. Epub 2011 Oct 15.
8
Tubal patency and fertility outcome after expectant management of ectopic pregnancy.异位妊娠期待治疗后的输卵管通畅情况及生育结局
Fertil Steril. 1997 Dec;68(6):1043-6. doi: 10.1016/s0015-0282(97)00414-7.
9
Reproductive outcomes after medical and surgical management of ectopic pregnancy.异位妊娠经药物和手术治疗后的生殖结局。
Clin Obstet Gynecol. 2012 Jun;55(2):455-60. doi: 10.1097/GRF.0b013e3182510a88.
10
Interventions for tubal ectopic pregnancy.输卵管异位妊娠的干预措施。
Cochrane Database Syst Rev. 2007 Jan 24;2007(1):CD000324. doi: 10.1002/14651858.CD000324.pub2.

引用本文的文献

1
Ethiodized poppyseed oil versus ioversol for image quality and adverse events in hysterosalpingography: a prospective cohort study.碘化罂粟籽油与碘佛醇在子宫输卵管造影中对图像质量和不良事件的比较:一项前瞻性队列研究。
BMC Med Imaging. 2019 Jun 24;19(1):50. doi: 10.1186/s12880-019-0346-0.
2
Current management of tubal infertility: from hysterosalpingography to ultrasonography and surgery.输卵管性不孕的当前管理:从子宫输卵管造影到超声检查及手术
J Med Life. 2015 Apr-Jun;8(2):157-9.
3
The Value of Hysterosalpingography following Medical Treatment with Methotrexate for Ectopic Pregnancy.甲氨蝶呤药物治疗异位妊娠后子宫输卵管造影的价值。
Obstet Gynecol Int. 2011;2011:547946. doi: 10.1155/2011/547946. Epub 2011 Sep 27.

本文引用的文献

1
Tubal patency after clinical treatment of unruptured ectopic pregnancy.未破裂型异位妊娠临床治疗后的输卵管通畅情况。
Int J Gynaecol Obstet. 2005 Mar;88(3):309-13. doi: 10.1016/j.ijgo.2004.12.018. Epub 2005 Jan 22.
2
Fertility outcome following combined methotrexate treatment of unruptured extrauterine pregnancy.甲氨蝶呤联合治疗未破裂宫外孕后的生育结局。
BJOG. 2000 May;107(5):626-30. doi: 10.1111/j.1471-0528.2000.tb13304.x.
3
Predictive score for the systemic treatment of unruptured ectopic pregnancy with a single dose of methotrexate.单剂量甲氨蝶呤全身治疗未破裂异位妊娠的预测评分
Int J Gynaecol Obstet. 1999 Nov;67(2):75-9. doi: 10.1016/s0020-7292(99)00114-9.
4
Predictors of success of methotrexate treatment in women with tubal ectopic pregnancies.输卵管异位妊娠女性甲氨蝶呤治疗成功的预测因素。
N Engl J Med. 1999 Dec 23;341(26):1974-8. doi: 10.1056/NEJM199912233412604.
5
Ruptured tubal ectopic pregnancy: risk factors and reproductive outcome: results of a population-based study in France.输卵管妊娠破裂:危险因素与生殖结局:法国一项基于人群研究的结果
Am J Obstet Gynecol. 1999 Apr;180(4):938-44. doi: 10.1016/s0002-9378(99)70665-4.
6
Tubal patency and fertility outcome after expectant management of ectopic pregnancy.异位妊娠期待治疗后的输卵管通畅情况及生育结局
Fertil Steril. 1997 Dec;68(6):1043-6. doi: 10.1016/s0015-0282(97)00414-7.
7
Is hysterosalpingography an important tool in predicting fertility outcome?
Fertil Steril. 1997 Apr;67(4):663-9. doi: 10.1016/s0015-0282(97)81363-5.
8
Pregnancy rate following normal versus abnormal hysterosalpingography findings: a meta-analysis.
Gynecol Obstet Invest. 1997;43(2):79-83. doi: 10.1159/000291826.
9
Observer variability in the diagnosis and management of the hysterosalpingogram.
Fertil Steril. 1997 Feb;67(2):233-7. doi: 10.1016/s0015-0282(97)81903-6.
10
Reproductive outcome after expectant management of ectopic pregnancy.异位妊娠期待治疗后的生殖结局。
Eur J Obstet Gynecol Reprod Biol. 1996 May;66(1):1-2. doi: 10.1016/0301-2115(95)02370-4.